For a Limited Time: Get 3 Years of Access at the Price of 1
Here is the latest financial fact sheet of VASA DENTICITY. For more details, see the VASA DENTICITY quarterly results and VASA DENTICITY share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -0.4 |
No. of shares | m | 16.02 |
1 Week | % | -1.4 |
1 Month | % | -8.6 |
1 Year | % | - |
52 week H/L | Rs | 730.0/211.0 |
No. of Mths Year Ending |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
VASA DENTICITY EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | NA | NA | NA | ||
Low | Rs | NA | NA | NA | NA | ||
Sales per share (Unadj.) | Rs | 1,520.9 | 2,003.6 | 3,846.1 | 96.0 | ||
Earnings per share (Unadj.) | Rs | 4.7 | 16.3 | 249.8 | 5.9 | ||
Diluted earnings per share | Rs | 0.1 | 0.2 | 3.1 | 4.7 | ||
Cash flow per share (Unadj.) | Rs | 8.7 | 21.0 | 265.5 | 6.3 | ||
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | ||
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | ||
Avg Dividend yield | % | 0 | 0 | 0 | 0 | ||
Book value per share (Unadj.) | Rs | 13.6 | 29.9 | 286.4 | 12.3 | ||
Adj. book value per share | Rs | 0.2 | 0.4 | 3.6 | 9.9 | ||
Shares outstanding (eoy) | m | 0.20 | 0.20 | 0.20 | 12.84 | ||
Price / Sales ratio | x | 0 | 0 | 0 | 0 | ||
Avg P/E ratio | x | 0 | 0 | 0 | 0 | ||
P/CF ratio (eoy) | x | 0 | 0 | 0 | 0 | ||
Price / Book Value ratio | x | 0 | 0 | 0 | 0 | ||
Dividend payout | % | 0 | 0 | 0 | 0 | ||
Avg Mkt Cap | Rs m | 0 | 0 | 0 | 0 | ||
Total wages/salary | Rs m | 24 | 17 | 41 | 71 |
VASA DENTICITY INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 304 | 401 | 769 | 1,233 | ||
Other income | Rs m | 0 | 1 | 2 | 5 | ||
Total revenues | Rs m | 305 | 402 | 771 | 1,238 | ||
Gross profit | Rs m | 2 | 5 | 56 | 104 | ||
Depreciation | Rs m | 1 | 1 | 3 | 5 | ||
Interest | Rs m | 1 | 1 | 5 | 4 | ||
Profit before tax | Rs m | 1 | 4 | 50 | 100 | ||
Minority Interest | Rs m | 0 | 0 | 0 | 0 | ||
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | ||
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | ||
Tax | Rs m | 0 | 1 | 0 | 24 | ||
Profit after tax | Rs m | 1 | 3 | 50 | 76 | ||
Gross profit margin | % | 0.8 | 1.2 | 7.3 | 8.4 | ||
Effective tax rate | % | -0.2 | 26.4 | 0.4 | 23.6 | ||
Net profit margin | % | 0.3 | 0.8 | 6.5 | 6.2 |
VASA DENTICITY BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 44 | 63 | 171 | 245 | ||
Current liabilities | Rs m | 43 | 60 | 115 | 126 | ||
Net working cap to sales | % | 0.2 | 0.7 | 7.4 | 9.7 | ||
Current ratio | x | 1.0 | 1.0 | 1.5 | 2.0 | ||
Inventory Days | Days | 0 | 0 | 6 | 8 | ||
Debtors Days | Days | 96 | 69 | 64 | 29 | ||
Net fixed assets | Rs m | 4 | 5 | 20 | 46 | ||
Share capital | Rs m | 2 | 2 | 2 | 128 | ||
"Free" reserves | Rs m | 1 | 4 | 55 | 30 | ||
Net worth | Rs m | 3 | 6 | 57 | 158 | ||
Long term debt | Rs m | 0 | 0 | 14 | 2 | ||
Total assets | Rs m | 48 | 68 | 191 | 292 | ||
Interest coverage | x | 2.1 | 7.9 | 11.5 | 26.1 | ||
Debt to equity ratio | x | 0 | 0 | 0.3 | 0 | ||
Sales to assets ratio | x | 6.4 | 5.9 | 4.0 | 4.2 | ||
Return on assets | % | 3.8 | 5.7 | 28.6 | 27.4 | ||
Return on equity | % | 34.7 | 54.5 | 87.2 | 48.0 | ||
Return on capital | % | 67.3 | 84.8 | 76.7 | 64.6 | ||
Exports to sales | % | 0 | 0 | 0 | 0 | ||
Imports to sales | % | 0 | 0.5 | 12.3 | 22.0 | ||
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | ||
Imports (cif) | Rs m | 0 | 2 | 95 | 271 | ||
Fx inflow | Rs m | 25 | 14 | 0 | 12 | ||
Fx outflow | Rs m | 0 | 2 | 95 | 271 | ||
Net fx | Rs m | 25 | 11 | -95 | -258 |
VASA DENTICITY CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 8 | -5 | 2 | 17 | ||
From Investments | Rs m | -4 | -13 | -4 | -10 | ||
From Financial Activity | Rs m | -1 | 13 | 8 | -1 | ||
Net Cashflow | Rs m | 3 | -5 | 6 | 6 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Vikas Agarwal | COMP SEC: Kriti Arora | YEAR OF INC: 2016 | NSE CODE: 700188 | FV (Rs): 10 | DIV YIELD (%): - |
More Trading Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare VASA DENTICITY With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
On Friday, Indian share markets traded on a positive note throughout the trading session and ended higher.